Back to LPCN

CITADEL ADVISORS LLC → LPCN

CITADEL ADVISORS LLC LPCN Position History

Lipocine Inc. • Healthcare

Quarters held
9
Latest value
$171K
Q3 2026
Peak value
$208K
First seen
Q1 2023

Dollar value over time

Show data table
PeriodPosition value
Q1 2023$9K
Q1 2023$286
Q1 2023$30K
Q3 2025$41K
Q1 2026$47K
Q1 2026$185K
Q2 2026$208K
Q2 2026$208K
Q3 2026$171K

Quarter-by-quarter history

Every disclosed snapshot of the position

QuarterValueShares% PortfolioChange
Q3 2026$171K77.7K——
Q2 2026$208K81.2K——
Q2 2026$208K81.2K——
Q1 2026$185K23.2K——
Q1 2026$47K5.9K——
Q3 2025$41K14.2K——
Q1 2023$30K93.4K——
Q1 2023$286900——
Q1 2023$9K29.8K——

Other funds holding LPCN

Other CITADEL ADVISORS LLC positions

ETHA

ISHARES TR

$13.2B
ETHA

ISHARES TR

$13.2B
ETHA

ISHARES TR

$11.2B
SPY

SPDR S&P 500 ETF TR

$3B
MSFT

MICROSOFT CORP

$2.9B
ETHA

ISHARES TR

$2.7B
SPY

SPDR S&P 500 ETF TR

$2.6B
SPY

STATE STR SPDR S&P 500 ETF T

$2.4B